CymaBay Therapeutics, Inc.
Treatment of intrahepatic cholestatic diseases
Last updated:
Abstract:
Treatment of intrahepatic cholestatic diseases by therapy with seladelpar or a salt thereof.
Status:
Application
Type:
Utility
Filling date:
3 Apr 2021
Issue date:
22 Jul 2021